We followed tumor growth and noted that HK2 + TCR-T cells mediated a significant delay in tumor growth compared to the control group that was treated with NGFR + TCR-transduced T cells (Figure 5C; n=6, p<0.01). The gene discussed is NGFR; the disease is neoplasm.